RETA
Blackstone Inc’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-340,793
| Closed | -$34.7M | – | 173 |
|
|
2023
Q2 | $34.7M | Hold |
340,793
| – | – | 0.15% | 50 |
|
|
2023
Q1 | $31M | Hold |
340,793
| – | – | 0.13% | 47 |
|
|
2022
Q4 | $12.9M | Hold |
340,793
| – | – | 0.05% | 59 |
|
|
2022
Q3 | $8.56M | Hold |
340,793
| – | – | 0.03% | 71 |
|
|
2022
Q2 | $10.4M | Hold |
340,793
| – | – | 0.03% | 83 |
|
|
2022
Q1 | $11.2M | Hold |
340,793
| – | – | 0.03% | 102 |
|
|
2021
Q4 | $8.99M | Hold |
340,793
| – | – | 0.02% | 140 |
|
|
2021
Q3 | $34.3M | Hold |
340,793
| – | – | 0.08% | 85 |
|
|
2021
Q2 | $48.2M | Hold |
340,793
| – | – | 0.11% | 63 |
|
|
2021
Q1 | $34M | Hold |
340,793
| – | – | 0.07% | 59 |
|
|
2020
Q4 | $42.1M | Buy |
340,793
+102,238
| +43% | +$12.6M | 0.15% | 48 |
|
|
2020
Q3 | $23.2M | Sell |
238,555
-40,530
| -15% | -$3.95M | 0.09% | 58 |
|
|
2020
Q2 | $43.5M | Buy |
+279,085
| New | +$43.5M | 0.18% | 38 |
|